1-4 of 4
Shaolin Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models

Available to Purchase
Katelyn F. Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph, Emine Bayraktar, Santosh K. Dasari, Nghi Nguyen, Reid T. Powell, Mary Sobieski, Cristina Ivan, Mark Kim, Sujanitha Umamaheswaran, Deanna Glassman, Yunfei Wen, Paola Amero, Clifford Stephan, Robert L. Coleman, Yosef Landesman, Shannon N. Westin, Prahlad T. Ram, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12): 2352–2361.
https://doi.org/10.1158/1535-7163.MCT-21-0370
Published: 03 December 2021
View articletitled, Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
Open the PDF for Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models in another window
Includes: Supplementary data
Journal Articles

Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer

Available to Purchase
Mark Seungwook Kim, Shaolin Ma, Anca Chelariu-Raicu, Carola Leuschner, Hector W. Alila, Sanghoon Lee, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (11): 2396–2406.
https://doi.org/10.1158/1535-7163.MCT-20-0030
Published: 03 November 2020
View articletitled, Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer
Open the PDF for Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

GnRH-R–Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition

Free
Shaolin Ma, Sunila Pradeep, Alejandro Villar-Prados, Yunfei Wen, Emine Bayraktar, Lingegowda S. Mangala, Mark Seungwook Kim, Sherry Y. Wu, Wei Hu, Cristian Rodriguez-Aguayo, Carola Leuschner, Xiaoyan Liang, Prahlad T. Ram, Katharina Schlacher, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (5): 969–979.
https://doi.org/10.1158/1535-7163.MCT-18-0770
Published: 01 May 2019
View articletitled, GnRH-R–Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition
Open the PDF for GnRH-R–Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition in another window
Includes: Supplementary data
Journal Articles

Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4

Free
Alejandro Villar-Prados, Sherry Y. Wu, Karem A. Court, Shaolin Ma, Christopher LaFargue, Mamur A. Chowdhury, Margaret I. Engelhardt, Cristina Ivan, Prahlad T. Ram, Ying Wang, Keith Baggerly, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Shyh-Ming Yang, David J. Maloney, Makoto Yoshioka, Jeffrey W. Strovel, Jason Roszik, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (2): 421–436.
https://doi.org/10.1158/1535-7163.MCT-18-0365
Published: 04 February 2019
View articletitled, Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4
Open the PDF for Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4 in another window
Includes: Supplementary data